4
Changes in Ownership
Allogene Therapeutics, Inc. Filed Acc 0001737287-26-000002
EVP of R&D sold 35,700 shares at $1.77 ($63,189)
From the SEC's structured data for this filing
Trades in this filing
Roberts Zachary · EVP of R&D
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-02 | Sale : show line 1 in the form | −35,700 | $1.77 | $63,189 | 581,166 | D |
| Open-market sales · 35,700 sh · avg $1.77 · $63,189 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-02 | Grant or award : show line 2 in the form Stock Option (Right to buy) | +718,763 | 718,763 | D |
| 2026-02-02 | Grant or award : show line 3 in the form Restricted Stock Unit | +203,307 | 203,307 | D |
Loading xslF345X05/wk-form4_1770242855.xml…